BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25843803)

  • 1. Tripartite motif 16 inhibits epithelial-mesenchymal transition and metastasis by down-regulating sonic hedgehog pathway in non-small cell lung cancer cells.
    Huo X; Li S; Shi T; Suo A; Ruan Z; Yao Y
    Biochem Biophys Res Commun; 2015 May; 460(4):1021-8. PubMed ID: 25843803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEM107 inhibits EMT and invasion of NSCLC through regulating the Hedgehog pathway.
    Xu H; Dun S; Gao Y; Ming J; Hui L; Qiu X
    Thorac Cancer; 2021 Jan; 12(1):79-89. PubMed ID: 33124203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells.
    Tan H; Qi J; Chu G; Liu Z
    Oncol Res; 2017 Apr; 25(4):551-558. PubMed ID: 27737724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion.
    Li L; Dong L; Qu X; Jin S; Lv X; Tan G
    Int J Oncol; 2016 Apr; 48(4):1639-49. PubMed ID: 26892350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway.
    Choe C; Shin YS; Kim SH; Jeon MJ; Choi SJ; Lee J; Kim J
    Anticancer Res; 2013 Sep; 33(9):3715-23. PubMed ID: 24023301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of RAD51AP1 suppresses epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Wu Y; Wang H; Qiao L; Jin X; Dong H; Wang Y
    Thorac Cancer; 2019 Sep; 10(9):1748-1763. PubMed ID: 31317661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
    Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
    Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
    J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gli promotes tumor progression through regulating epithelial-mesenchymal transition in non-small-cell lung cancer.
    Jiang L; Huang J; Hu Y; Lu P; Luo Q; Wang L
    J Cardiothorac Surg; 2020 Jan; 15(1):18. PubMed ID: 31931858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
    Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
    Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
    Wang B; Tang Z; Gong H; Zhu L; Liu X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor POU4F2 promotes colorectal cancer cell migration and invasion through hedgehog-mediated epithelial-mesenchymal transition.
    Guo K; Wang P; Zhang L; Zhou Y; Dai X; Yan Y; Chen Y; Wasan HS; Yu J; Ruan S; Sun L
    Cancer Sci; 2021 Oct; 112(10):4176-4186. PubMed ID: 34327778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.